Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation

American Journal of Cardiology

Volumn 86, Issue 7, 2000, Pages 795-797

  Li Saw Hee, Foo Leong ^a   Blann, Andrew D ^a   Lip, Gregory Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOTTING; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOGENESIS; THROMBOSIS;

AGED; ATRIAL FIBRILLATION; BLOOD COAGULATION; BLOOD PRESSURE; CHRONIC DISEASE; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMAN; MALE; MIDDLE AGE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; VON WILLEBRAND FACTOR;

EID: 0034307094     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01086-9     Document Type: Article

References (14)

1. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke the Framingham Study . Stroke. 22:1991;983-988.
2. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J. Blood pressure, stroke, and coronary artery heart disease. Part 1, prolonged difference in blood pressure prospective observational studies corrected for the regression dilution bias . Lancet. 335:1990;765-774.
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomised controlled trials . Arch Intern Med. 154:1994;1449-1457.
4. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin Stroke Prevention in Atrial Fibrillation III Study . JAMA. 279:1998;1273-1277.
5. Lee M.L., Rosner B.A., Weiss S.T. Relationship of blood pressure to cardiovascular death the effects of pulse pressure in the elderly . Ann Epidemiol. 9:1999;101-107.
6. Lip G.Y.H., Li-Saw-Hee F.L. Does hypertension confer a hypercoagulable state? J Hypertens. 16:1998;913-916.
7. Lee A.J. The role of rheological and haemostatic factors in hypertension. J Hum Hypertens. 11:1997;767-776.
8. Lip G.Y.H. Hypercoagulability and haemodynamic abnormalities in atrial fibrillation. Heart. 77:1997;395.
9. Junker R., Heinrich J., Schulte H., Erren M., Assman G. Haemostasis in normotensive and hypertensive men results of the PROCAM study . J Hypertens. 16:1998;917-923.
10. Lip G.Y.H., Lowe D.O., Rumley A., Dunn F.G. Increased markers of thrombogenesis in chronic atrial fibrillation Effects of warfarin therapy . Br Heart J. 73:1995;527-533.
11. Kumagai K., Fukunami M., Kitabatake A., Kamada T., Hoki N. Increased cardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol. 16:1990;377-380.
12. Blann A.D., Naqvi T., Waite M., McCollum C.N. Von Willebrand factor and endothelial cell damage in essential hypertension. J Hum Hypertens. 7:1993;107-111.
13. Heppell R.M., Berkin K.E., McLenachan J.M., Davies J.A. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart. 77:1997;407-411.
14. Lip G.Y., Blann A.D., Jones A.F., Lip P.L., Beevers D.G. Relationship of endothelium, thrombogenesis, and haemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol. 80:1997;1566-1571.